#GTPL-305

Now stock price above 1.272%(233)
And 1.618%(288)

Next objetive is to move higher towards Fibonacci extension

2.618%(446)

and other Fibonacci extension in time to come.

#Probability

FESTIVE SEASON FOCUS @ETNowSwadesh

SHRADH HOGA KHATAM, AB FESTIVE SEASON SHURU!!

KHULEGA INDIA, BADEGA INDIA!!

Shraadh ends on Oct.6
Navratri starts on Oct.7
Durga Puja starts on Oct.11

TRIGGERS

Gifting season starts ahead of festival season (Amazon+Flipkart Sale)

Strong rural sentiments due to good rainfall + Higher MSP

Cities see rise in average salary across board

Record vaccination numbers seen across the country

Low interest rates propel demand

CUTLERY STOCKS
LA OPALA
TTK PRESTIGE

FOOD STOCKS
KRBL
PARAG MILK FOODS
DODLA DIARY

RETAIL CLOTHES
SHOPPERS STOP
ADITYA BIRLA FASHION RETAIL
V-MART RETAIL

SHOES STOCKS
BATA
RELAXO SOFTWARE
MIRZA INTERNATIONAL

#lauruslabs

Breakout > 630

Tata Elxsi :
An example of a multi-bagger !!!
Breaking out again...
#tataelxsi
#nifty
#banknifty
#niftyit
#EquityDynamo

There are 2 more days to this week but if the current trend is maintained then #HindCopper may close above 130 on Friday. Price is yet to breakout but RSI has already broken out. Let's review on weekly

Repeating - the stocks that are relatively stronger than Nifty or against their respective sectors for the past THREE MONTHS will keep on performing well for the subsequent 9-12 months. A study was also done by Mebane T. Faber. The study is available for free on the Net as a pdf.

Stocks to Watch out

1. Team Lease
2. BEML
3. Radico Khaitan
4. Advanced Enzymes

Charts to Try

1. Nifty 50
2. CNX Mid Cap
3. CNX Small Cap

I would suggest to try's the above 3 mentioned and analyze

#HINDCOPPER
ALL THE HINDCOPPER LOVERS STOCK IS GETTING READY FOR 210++ LEVELS
#ELLIOTTWAVE

#Alkaliamines
1 active bullish ABC 1 Probable Bullish ABC
keep sl 3600 for 4800/5800
#AhmedabadNest #RelativeStrength #Outperformance #investing #India

#HDFCBank

Probable Double Top Buy is associated with multiple bearish failures.

Bullish Breakouts associated with Bearish failures has an extra flavor of bullishness as there is an ingredient of failure of the other side

Just got this email from the Indian Hotels Company
Good campaign #DekhoApnaDesh
Especially when most of the holidays are happening domestically. No wonder the Stock is Strong.

This is just information sharing. I may be holding this stock. Please do your own research.

#LTTS

Regression channel usually saves the trend to stay intact. LTTS looks so oversold yet strongly uptrending
Quite a setup it is !!

#IRCTC
#Intraday

Bullish ABC FT probable

TATAPOWER - 39% +
A clear 9R trade based on the

50BANDS STRATEGY

Strictly followed the rules of the strategy!

https://t.co/w4N9gNIF1T

Over 37k+ Views!

Tataelxsi :
Forming Flag of HTF.
Uniform runup along the Ema suggests strong uptrend continuation pattern.

#IRCTC
A brief consolidation, before continuing to move in prior direction of the trend.

Broken past the converging trendlines; A follow-through here and a closing above 4019.70 would bring in the targets of 4240 followed by 4450.

Thread on Drug Development process 🧵

Hit like & Retweet for more learnings ! 💊🧪🩺💉
@unseenvalue

Topics Covered :
1.Introduction to CRO,CDMO,CMO & CRAMS
2.Discovery
3.Clinical Trials
4.Commercialization and Surveillance
5.Success Rates
6.CRO
7.CMO
8.CDMO
9.CRAMS

1. Introduction :
What are CROs, CDMOs, CMOs and CRAMS? How are they different from each other and what value do they add to the Pharma Value Chain? To understand these concepts, we took a look at the drug discovery process.

The APIs manufactured by our Indian players lie at the end of this value chain. There is a whole process that comes before it that takes a lot more time and costs a lot of money.

On average, it takes about 10 to 15 years for a drug to make it to market. It costs hundreds of millions, if not billions of dollars to bring one drug to market.

A drug goes through 3 big phases on it’s way to make it to market - the discovery phase, clinical testing phase and the commercialization phase. Once we understand these phases, it makes it easy to understand the role of CROs and CDMOs